Holen Sie sich die Stockscreener-App
1.96
11.36%
0.20
Schlusskurs vom Vortag:
$1.76
Offen:
$1.8
24-Stunden-Volumen:
1.13M
Relative Volume:
1.75
Marktkapitalisierung:
$70.46M
Einnahmen:
$210.70K
Nettoeinkommen (Verlust:
$-21.37M
KGV:
-1.7818
EPS:
-1.1
Netto-Cashflow:
$-21.10M
1W Leistung:
-1.01%
1M Leistung:
+10.73%
6M Leistung:
-4.39%
1J Leistung:
-21.60%
1-Tages-Spanne:
$1.775
$1.98
1-Wochen-Bereich:
$1.74
$2.08
52-Wochen-Spanne:
$1.41
$2.81
Gain Therapeutics Inc Stock (GANX) Company Profile
Firmenname
Gain Therapeutics Inc
Sektor
Branche
Telefon
(301) 500-1556
Adresse
4800 HAMPDEN LANE, BETHESDA
Vergleichen Sie GANX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GANX
Gain Therapeutics Inc
|
1.96 | 63.27M | 210.70K | -21.37M | -21.10M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | -52.09M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Gain Therapeutics Inc Stock (GANX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-12-06 | Eingeleitet | ROTH MKM | Buy |
| 2024-08-14 | Fortgesetzt | Oppenheimer | Outperform |
| 2021-04-12 | Eingeleitet | BTIG Research | Buy |
| 2021-04-12 | Eingeleitet | Oppenheimer | Outperform |
Gain Therapeutics Inc Aktie (GANX) Neueste Nachrichten
Can Gain Therapeutics Inc. stock deliver sustainable ROETrade Volume Report & Weekly Setup with ROI Potential - newser.com
Is Gain Therapeutics Inc. stock a buy before product launchesPortfolio Risk Summary & Safe Entry Trade Signal Reports - newser.com
Using R and stats models for Gain Therapeutics Inc. forecastingJuly 2025 Institutional & Verified Swing Trading Watchlist - newser.com
Will Gain Therapeutics Inc. stock deliver strong dividend growthJuly 2025 Levels & Smart Allocation Stock Tips - newser.com
Sentiment analysis tools applied to Gain Therapeutics Inc.Quarterly Trade Review & Weekly Market Pulse Updates - newser.com
Advanced analytics toolkit walkthrough for Gain Therapeutics Inc.Risk Management & Fast Moving Market Watchlists - newser.com
Is Gain Therapeutics Inc. stock a dividend growth opportunityJuly 2025 Closing Moves & High Accuracy Trade Alerts - newser.com
Gain Therapeutics Inc. stock trend outlook and recovery pathWeekly Profit Summary & Fast Exit and Entry Strategy Plans - newser.com
How risky is Gain Therapeutics Inc. stock nowMarket Trend Review & Stepwise Trade Signal Implementation - newser.com
Using Python tools to backtest Gain Therapeutics Inc. strategiesMarket Movement Recap & Reliable Breakout Forecasts - newser.com
Is Gain Therapeutics Inc. stock entering bullish territoryJuly 2025 Update & Fast Entry High Yield Tips - newser.com
Is Gain Therapeutics Inc. stock ready for a breakoutJuly 2025 WrapUp & Daily Volume Surge Signals - newser.com
Gain Therapeutics, Inc. (NASDAQ:GANX) Short Interest Up 200.7% in October - MarketBeat
Gain Therapeutics, Inc. (GANX) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Can machine learning forecast Gain Therapeutics Inc. recoveryJuly 2025 Spike Watch & Growth Focused Investment Plans - newser.com
Gain Therapeutics Advances Parkinson’s Treatment with GT-02287 Study - MSN
Gain Therapeutics to Present at Neuroscience 2025 - The Manila Times
Gain Therapeutics (NASDAQ: GANX) to present GT-02287 poster at Society for Neuroscience - Stock Titan
What technical charts say about Gain Therapeutics Inc. stock2025 Historical Comparison & Fast Gain Stock Trading Tips - newser.com
Is Gain Therapeutics Inc. stock undervalued vs historical averagesWeekly Market Outlook & Accurate Technical Buy Alerts - newser.com
What drives Gain Therapeutics Inc stock priceTechnical Breakout Signals & Free Real-Time Stock Market Data - earlytimes.in
How Gain Therapeutics Inc. stock reacts to inflationary pressuresProfit Target & Weekly Return Optimization Alerts - fcp.pa.gov.br
What risks investors should watch in Gain Therapeutics Inc. stockJuly 2025 Retail & Stock Portfolio Risk Management - fcp.pa.gov.br
Finanzdaten der Gain Therapeutics Inc-Aktie (GANX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):